Neumirna
Pre-clinicalDeveloping miRNA-based therapies targeting root causes of neurological diseases like epilepsy and Parkinson's. Transforming outcomes beyond symptom management.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $4.2M
About
Developing miRNA-based therapies targeting root causes of neurological diseases like epilepsy and Parkinson's. Transforming outcomes beyond symptom management.
RNA & Gene Therapy
Funding History
1Total raised:$4.2M
Seed$4.2MSep 15, 2022